次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

医薬品原薬(API)の世界市場:2025年に至る合成API/バイオAPI別、治療領域別予測

Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2020年9月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文320ページになります。
商品コード:MAM2166

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
医薬品原薬(API)の世界市場規模は2020年で1873億ドル、2025年には2483億ドルへ増加するとレポートでは予測しています。当レポートでは、2025年に至る医薬品原薬(API)の世界市場予測(市場規模US$)、タイプ別市場(新薬、ジェネリック医薬品)、メーカータイプ別市場(自家用APIメーカー、商用APIメーカー)、合成タイプ別市場(合成API各種、バイオAPI各種)、医薬品タイプ別市場(処方薬、一般用医薬品)、効能別市場(API、高薬理API)、治療領域別市場(伝染病、腫瘍、糖尿病、心血管疾患、疼痛管理、呼吸器疾患、その他)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業20社プロフィール動向などの情報も交えて、医薬品原薬(API)市場の現在と今後展開を予測分析していきます。

【レポート構成概要】
◆医薬品原薬(API)の世界市場予測2018-2025年
・市場規模(US$)

◆タイプ別、市場-2025年
・新薬
・ジェネリック医薬品
※(市場規模US$)

◆メーカータイプ別、市場-2025年
<自家用APIメーカー>

<商用APIメーカー>
タイプ別
・新薬
・ジェネリック医薬品

合成タイプ
・合成API
・バイオAPI
※(市場規模US$)

◆合成タイプ別、市場-2025年
<合成API>
合成API、タイプ別
・新薬
・ジェネリック医薬品

<バイオAPI>
バイオAPI、タイプ別
・新薬
・ジェネリック医薬品

バイオAPI、製品別
・モノクローナル抗体
・ホルモン/成長因子
・サイトカイン
・融合タンパク質
・組み換えワクチン
・治療用酵素
・血液因子

バイオAPI、発現系別
・哺乳動物発現系
・微生物発現系
・酵母発現系
・昆虫発現系
・その他発現系
※(市場規模US$)

◆医薬品タイプ別、市場-2025年
・処方薬
・一般用医薬品(OTC)
※(市場規模US$)

◆効能別、市場-2025年
・API
・高薬理API
※(市場規模US$)

◆治療領域別、市場-2025年
・伝染病
・腫瘍
・糖尿病
・心血管疾患
・疼痛管理
・呼吸器疾患
・その他
※(市場規模US$)

◆主要国地域別市場-2025年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン、ハンガリー
・その他欧州
アジア
・日本、中国、インド、韓国
・その他アジア
その他地域
・イスラエル
・その他地域
※国地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19による影響
・バリューチェーン分析
・エコシステム分析
・競合状況

◆医薬品原薬(API)の主要企業プロフィール動向
・PFIZER, INC.
・NOVARTIS AG
・SANOFI
・BOEHRINGER INGELHEIM
・BRISTOL-MYERS SQUIBB
・TEVA PHARMACEUTICAL INDUSTRIES LTD.
・ELI LILLY AND COMPANY
・GLAXOSMITHKLINE PLC
・MERCK & CO., INC.
・MYLAN N.V.
・ABBVIE INC.
・F. HOFFMANN-LA ROCHE LTD.
・ASTRAZENECA
・DR. REDDY’S LABORATORIES LTD.
・SUN PHARMACEUTICAL INDUSTRIES LTD.
・CIPLA, INC.
・API PHARMA TECH
・BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
・SREEPATHI PHARMACEUTICALS LIMITED
・SHILPA MEDICARE LIMITED

(全320頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 52
・       FIGURE 1........................................... MARKET SEGMENTATION
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS
1.7             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 2.................................................. RESEARCH DESIGN.. 55
2.1.1              SECONDARY SOURCES.. 56
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY SOURCES.. 57
2.1.2.1            PRIMARY SOURCES
2.1.2.2            KEY DATA FROM PRIMARY SOURCES
・       FIGURE 3......................... BREAKDOWN OF PRIMARY INTERVIEWS
2.2             MARKET SIZE ESTIMATION
・       FIGURE 4..... MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・       FIGURE 5...... MARKET SIZE ESTIMATION: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
2.3             MARKET BREAKDOWN AND DATA TRIANGULATION
・       FIGURE 6.......................... DATA TRIANGULATION METHODOLOGY
2.4             MARKET SHARE ESTIMATION
2.5             ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

・       FIGURE 7 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
・       FIGURE 8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2020 VS. 2025 (USD BILLION)
・       FIGURE 9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020 VS. 2025 (USD BILLION)
・       FIGURE 10......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT,  2020 VS. 2025 (USD BILLION)
・       FIGURE 11..... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020 VS. 2025 (USD BILLION)
・       FIGURE 12................... GEOGRAPHICAL SNAPSHOT OF THE ACTIVE PHARMACEUTICAL
INGREDIENTS MARKET

4.... PREMIUM INSIGHTS

4.1             ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
・       FIGURE 13..... INCREASING INCIDENCE OF CHRONIC DISEASES AND GROWING IMPORTANCE OF GENERICS ARE THE KEY FACTORS DRIVING MARKET GROWTH
4.2             NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE & TYPE OF MANUFACTURER (2019)
・       FIGURE 14.......... INNOVATIVE APIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
4.3             ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・       FIGURE 15... CHINA TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
5.2.1              DRIVERS
5.2.1.1            INCREASING INCIDENCE OF CHRONIC DISEASES
5.2.1.2            TECHNOLOGICAL ADVANCEMENTS IN API MANUFACTURING
5.2.1.3            GROWING IMPORTANCE OF GENERICS
・       TABLE 1.......... INDICATIVE LIST OF DRUGS GOING GENERIC IN 2020
5.2.1.4            INCREASING UPTAKE OF BIOPHARMACEUTICALS
・       TABLE 2.. INDICATIVE LIST OF BIOLOGICS THAT GAINED REGULATORY APPROVAL IN THE US IN 2019
5.2.1.5            GROWING ADOPTION OF AI-BASED TOOLS FOR DRUG DISCOVERY
5.2.1.6            ADOPTION OF ORGAN-ON-CHIP MODELS IN DRUG DEVELOPMENT
5.2.1.7            FOCUS ON PRECISION MEDICINE
5.2.1.8            INVESTMENTS IN REAL-WORLD EVIDENCE BY PHARMACEUTICAL COMPANIES
5.2.2              RESTRAINTS
5.2.2.1            UNFAVORABLE DRUG PRICE CONTROL POLICIES
5.2.2.2            HIGH MANUFACTURING COSTS
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGING BIOSIMILARS MARKET
・       TABLE 3 INDICATIVE LIST OF BIOSIMILARS THAT GAINED REGULATORY APPROVAL IN THE US (2019–2020)
5.2.3.2            HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
5.2.3.3            EMERGING MARKETS
5.2.3.4            EMERGING TECHNOLOGIES
5.2.4              CHALLENGES
5.2.4.1            INCREASING PENETRATION OF COUNTERFEIT DRUGS

5.3             IMPACT OF COVID-19 ON THE MARKET
・       TABLE 4....... INDICATIVE LIST OF COVID-19 THERAPEUTIC DRUGS IN
THE PIPELINE (CLINICAL)
5.3.1              COVID-19 DRUG R&D: KEY DEVELOPMENTS
5.3.2              COVID-19 DRUG R&D: VACCINE PRODUCTION SCENARIO, BY COUNTRY
5.4             VALUE CHAIN ANALYSIS.. 85
・       FIGURE 16.. MAJOR VALUE IS ADDED DURING THE MANUFACTURING
AND ASSEMBLY PHASE
5.5             SUPPLY CHAIN ANALYSIS
・       FIGURE 17.......... DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6             ECOSYSTEM ANALYSIS OF THE PHARMACEUTICALS MARKET
・       FIGURE 18........ ECOSYSTEM ANALYSIS OF THE PHARMACEUTICALS MARKET

6.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE

6.1             INTRODUCTION
・       TABLE 5.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
6.2             INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS
6.2.1              GROWING NUMBER OF NEW MOLECULAR ENTITIES GAINING REGULATORY APPROVALS TO DRIVE MARKET GROWTH
・       TABLE 6 INDICATIVE LIST OF BIOLOGICAL PRODUCTS THAT GAINED US FDA APPROVAL IN 2019
・       TABLE 7 LIST OF MAJOR DRUGS SET TO LOSE PATENT PROTECTION IN 2020
・       TABLE 8......... INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION). 92
・       TABLE 9.... NORTH AMERICA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 10.............. EUROPE: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 11 ASIA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
6.3             GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS
6.3.1              GOVERNMENT INITIATIVES SUPPORTING THE ADOPTION OF GENERIC DRUGS TO BOOST MARKET GROWTH
・       TABLE 12 GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 13...... NORTH AMERICA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 14 EUROPE: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 15.... ASIA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)

7.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER

7.1             INTRODUCTION
・       TABLE 16........... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
7.2             CAPTIVE API MANUFACTURERS
7.2.1              HIGH MANUFACTURING FLEXIBILITY AND ASSURANCE OF PRODUCT QUALITY ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
・       TABLE 17........ CAPTIVE API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 18 NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 19....... EUROPE: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 20............ ASIA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
7.3             MERCHANT API MANUFACTURERS
・       TABLE 21.... MERCHANT API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 22........ NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 23... EUROPE: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 24........ ASIA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
7.3.1              MERCHANT API MANUFACTURERS MARKET, BY TYPE
・       TABLE 25........ MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
7.3.1.1            INNOVATIVE API MANUFACTURERS
7.3.1.1.1            IMPENDING PATENT EXPIRIES AND INCREASING COSTS OF INNOVATIVE DRUGS MAY RESTRAIN THE MARKET GROWTH
・       TABLE 26... INNOVATIVE API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 27........ NORTH AMERICA: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 28... EUROPE: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 29....... ASIA: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
7.3.1.2            GENERIC API MANUFACTURERS
7.3.1.2.1            LOW MANUFACTURING COST OF GENERICS WILL DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 30....... GENERIC API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 31 NORTH AMERICA: GENERIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 32...... EUROPE: GENERIC API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 33........... ASIA: GENERIC API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
7.3.2              MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
・       TABLE 34..... MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
2018–2025 (USD BILLION)
7.3.2.1            SYNTHETIC API MANUFACTURERS
7.3.2.1.1            NEED FOR SPECIALIZED MANUFACTURING CAPABILITIES IS DRIVING THE GROWTH OF THIS SEGMENT
・       TABLE 35..... SYNTHETIC API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 36......... NORTH AMERICA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 37.... EUROPE: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 38......... ASIA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
7.3.2.2            BIOTECH API MANUFACTURERS
7.3.2.2.1            COMPLEXITY OF MANUFACTURING BIOTECH APIS HAS INCREASED THE FOCUS ON PARTNERSHIPS BETWEEN COMPANIES AND CMOS
・       TABLE 39....... BIOTECH API MANUFACTURERS MARKET, BY REGION,
2018–2025 (USD BILLION)
・       TABLE 40 NORTH AMERICA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 41....... EUROPE: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 42........... ASIA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)

8.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS

8.1             INTRODUCTION
・       TABLE 43. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
8.2             SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
・       TABLE 44......... SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION). 112
・       TABLE 45.... NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 46............... EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 47. ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
8.2.1              SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
・       TABLE 48......... SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
8.2.1.1            INNOVATIVE SYNTHETIC APIS
8.2.1.1.1            HIGH VALUE OF INNOVATIVE APIS TO DRIVE THE GROWTH OF THIS SEGMENT. 114
・       TABLE 49........... INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 50............ NORTH AMERICA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 51 EUROPE: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION). 115
・       TABLE 52... ASIA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION). 115
8.2.1.2            GENERIC SYNTHETIC APIS
8.2.1.2.1            INITIATIVES TO PROMOTE THE PENETRATION OF GENERICS WILL DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 53............... GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY REGION, 2018–2025 (USD BILLION)
・       TABLE 54................ NORTH AMERICA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 55... EUROPE: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION). 117
・       TABLE 56....... ASIA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
8.3             BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
・       TABLE 57.................................. TOP SELLING BIOLOGICS (2018)
・       TABLE 58 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 59....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 60 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 61.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
8.3.1              BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
・       TABLE 62 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
8.3.1.1            INNOVATIVE BIOTECH APIS
8.3.1.1.1            GROWING DEMAND FOR INNOVATIVE BIOPHARMACEUTICALS TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 63.............. INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY REGION, 2018–2025 (USD BILLION)
・       TABLE 64............... NORTH AMERICA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 65.. EUROPE: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION). 122
・       TABLE 66...... ASIA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.1.2            GENERIC BIOTECH APIS
8.3.1.2.1            INCREASING DEMAND FOR BIOSIMILAR DRUGS DUE TO THEIR COST-EFFECTIVENESS TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 67 INDICATIVE LIST OF BIOSIMILARS THAT GAINED THE US FDA APPROVAL
IN 2019
・       TABLE 68 GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY REGION, 2018–2025 (USD BILLION)
・       TABLE 69................... NORTH AMERICA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 70..... EUROPE: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 71.......... ASIA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2              BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
・       TABLE 72 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT 2018–2025 (USD BILLION)
8.3.2.1            MONOCLONAL ANTIBODIES
8.3.2.1.1            GROWING APPLICATIONS OF ANTIBODY-DRUG CONJUGATES IN THE TREATMENT OF CANCER TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 73........ INDICATIVE LIST OF MONOCLONAL ANTIBODIES THAT RECEIVED FDA APPROVAL IN 2019
・       TABLE 74 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 75....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 76 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 77.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.2            HORMONES & GROWTH FACTORS
8.3.2.2.1            THE GROWING INCIDENCE OF HORMONAL DISORDERS WILL DRIVE MARKET GROWTH.. 128
・       TABLE 78 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 79....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 80 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 81.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.3            CYTOKINES
8.3.2.3.1            INTERFERONS AND INTERLEUKINS BOOST THE IMMUNE SYSTEM AND HAVE IMPORTANT APPLICATIONS IN CANCER TREATMENT
・       TABLE 82 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 83....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 84 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 85.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.4            FUSION PROTEINS
8.3.2.4.1            GROWING APPLICATIONS OF FUSION PROTEINS IN BIOPHARMACEUTICALS TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 86 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 2018–2025 (USD BILLION). 132
・       TABLE 87....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 88 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 89.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.5            RECOMBINANT VACCINES
8.3.2.5.1            GROWING PREVALENCE OF INFECTIOUS DISEASES HAS BOOSTED VACCINE DEVELOPMENT—A POSITIVE INDICATOR OF GROWTH
・       TABLE 90 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 91....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 92 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 93.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.6            THERAPEUTIC ENZYMES
8.3.2.6.1            GROWING SIGNIFICANCE OF ENZYMES IN THERAPIES FOR CANCER AND PAIN MANAGEMENT WILL DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 94 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 95....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 96 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 97.... ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.2.7            BLOOD FACTORS
8.3.2.7.1            GROWING INCIDENCE OF HEMOPHILIA TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 98 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 99....... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 100................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 101.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.3              BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM
・       TABLE 102.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
8.3.3.1            MAMMALIAN EXPRESSION SYSTEMS
8.3.3.1.1            THEIR ABILITY TO CARRY POST-TRANSLATIONAL MODIFICATIONS WILL DRIVE THE MARKET FOR THESE SYSTEMS
・       TABLE 103.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 104..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 105................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 106.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
8.3.3.2            MICROBIAL EXPRESSION SYSTEMS
8.3.3.2.1            THESE SYSTEMS PROVIDE HIGH EXPRESSION LEVELS OF PROTEINS, WHICH SUPPORTS THEIR USE
・       TABLE 107.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 108..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 109................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 110.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
8.3.3.3            YEAST EXPRESSION SYSTEMS
8.3.3.3.1            ADVANTAGES SUCH AS EFFICIENT PROTEIN SECRETION, SIMPLE PURIFICATION, AND ENDOTOXIN-FREE PRODUCTS TO BOOST DEMAND
・       TABLE 111.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 112..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 113................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 114.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.3.4            INSECT EXPRESSION SYSTEMS
8.3.3.4.1            EFFICIENT POST-TRANSLATIONAL MODIFICATIONS PROVIDED BY THESE SYSTEMS TO BOOST THEIR DEMAND
・       TABLE 115.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 116..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 117................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 118.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
8.3.3.5            OTHER EXPRESSION SYSTEMS
・       TABLE 119.......... BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 120..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 121................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 122.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)

9.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG

9.1             INTRODUCTION
・       TABLE 123 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG,
2018–2025 (USD BILLION)
9.2             PRESCRIPTION DRUGS
9.2.1              GROWING DISEASE PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
・       TABLE 124 PRESCRIPTION DRUGS MARKET, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 125..... NORTH AMERICA: PRESCRIPTION DRUGS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 126.. EUROPE: PRESCRIPTION DRUGS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 127....... ASIA: PRESCRIPTION DRUGS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
9.3             OVER-THE-COUNTER DRUGS
9.3.1              SALES OF OTC DRUGS HAVE RISEN DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS
・       TABLE 128......... OVER-THE-COUNTER DRUGS MARKET, BY REGION,
2018-2025 (USD BILLION)
・       TABLE 129.. NORTH AMERICA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 130......... EUROPE: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
・       TABLE 131 ASIA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY,
2018–2025 (USD BILLION)
9.4             ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY
9.4.1              LOW-TO-MODERATE-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
9.4.1.1            HIGHER SAFETY, GOOD WARNING PROPERTIES, AND LACK OF GENIC EFFECTS CHARACTERIZE LOW-TO-MODERATE-POTENCY APIS
9.4.2              POTENT-TO-HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
9.4.2.1            MOST DRUGS UNDER DEVELOPMENT FALL INTO THIS CATEGORY
・       TABLE 132...... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)

10.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION

10.1          INTRODUCTION
・       TABLE 133...... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
10.2          COMMUNICABLE DISEASES
10.2.1            INCREASING GLOBAL INCIDENCE OF COMMUNICABLE DISEASES TO DRIVE MARKET GROWTH
・       TABLE 134.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 135................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 136......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 137... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
10.3          ONCOLOGY
10.3.1            INCREASING SPENDING ON CANCER MEDICATION TO SUPPORT THE GROWTH OF THIS SEGMENT
・       TABLE 138.. INDICATIVE LIST OF THE US FDA-APPROVED DRUGS FOR ONCOLOGY (2018)
・       TABLE 139.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY,
BY REGION, 2018–2025 (USD BILLION)
・       TABLE 140................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 141......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 142... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY,
BY COUNTRY, 2018–2025 (USD BILLION)
10.4          DIABETES
10.4.1            HIGH GLOBAL PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 143.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES,
BY REGION, 2018–2025 (USD BILLION)
・       TABLE 144................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 145......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 146... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES,
BY COUNTRY, 2018–2025 (USD BILLION)
10.5          CARDIOVASCULAR DISEASES
10.5.1            GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES IS A MAJOR GROWTH DRIVER
・       TABLE 147.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 148................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 149......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 150... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
10.6          PAIN MANAGEMENT
10.6.1            INCREASING DEMAND FOR INNOVATIVE AND ADVANCED PAIN MEDICATIONS IS A MAJOR GROWTH DRIVER FOR THIS MARKET
・       TABLE 151.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 2018–2025 (USD BILLION). 165
・       TABLE 152................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 153......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 154... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
10.7          RESPIRATORY DISEASES
10.7.1            HIGH GLOBAL PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 155.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 156................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 157......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 158... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
10.8          OTHER THERAPEUTIC APPLICATIONS
・       TABLE 159.... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2018–2025 (USD BILLION)
・       TABLE 160................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 161......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 162... ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)

11.. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION

11.1          INTRODUCTION
・       TABLE 163...... ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION,
2018–2025 (USD BILLION)
11.2          NORTH AMERICA
・       FIGURE 19................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
・       TABLE 164................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 165................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 166................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 167....... NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION). 175
・       TABLE 168....... NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 169................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 170.. NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 171..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 172..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 173..... NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 174................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 175................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 177
・       TABLE 176................. NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.2.1            US
11.2.1.1          THE US IS THE LARGEST MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENTS IN NORTH AMERICA
・       TABLE 177 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 178 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 179. US: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 180.. US: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 181 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 182.. US: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 183.... US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 184.... US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 185.... US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 186 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 187 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)
・       TABLE 188 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.2.2            CANADA
11.2.2.1          SUPPORT FROM GOVERNMENT ORGANIZATIONS IS DRIVING THE GROWTH OF THE APIS MARKET IN CANADA
・       TABLE 189......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 190......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 191. CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 192. CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 193......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 194............. CANADA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 195................ CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 196................ CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 197................ CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 198......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 199......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 187
・       TABLE 200......... CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)

11.3          EUROPE
・       TABLE 201......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION). 188
・       TABLE 202......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 203......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 204.. EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 205.. EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 206......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 207............. EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 208................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 209................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 210................ EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 211......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 212......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 191
・       TABLE 213......... EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.1            GERMANY
11.3.1.1          GERMANY DOMINATES THE EUROPEAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
・       TABLE 214....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 215....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 216 GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 217 GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 218....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 219........... GERMANY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
 BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 220............. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 221............. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 222............. GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 223....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 224....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 196
・       TABLE 225....... GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.2            FRANCE
11.3.2.1          AN INCREASE IN ANNUAL PHARMACEUTICAL INDUSTRY TURNOVER WILL SUPPORT MARKET GROWTH IN FRANCE
・       TABLE 226.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 227.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 228.. FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 229.. FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 230.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 231............. FRANCE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 232................ FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 233................ FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 234................ FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 235.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 236.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 200
・       TABLE 237.......... FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.3            UK
11.3.3.1          RISING GOVERNMENT INVESTMENTS WILL DRIVE THE GROWTH OF THE UK MARKET
・       TABLE 238 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 239 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 240. UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 241.. UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 242 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 243.. UK: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 244.... UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 245.... UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 246.... UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 247 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 248 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)
・       TABLE 249 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.4            ITALY
11.3.4.1          GROWING INVESTMENT IN API PRODUCTION WILL SUPPORT MARKET GROWTH.. 206
・       TABLE 250. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 251. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 252..... ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 253..... ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 254. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 255 ITALY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 256. ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 257. ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 258. ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 259. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 260. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 261. ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.5            SPAIN
11.3.5.1          THE SPANISH MARKET HAS BEEN TYPICALLY DOMINATED BY BRANDED DRUGS
・       TABLE 262 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 263 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 264.... SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 265.... SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 266 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 267................ SPAIN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 268 SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 269 SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 270 SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 271 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 272 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 273 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.6            HUNGARY
11.3.6.1          RISING INCIDENCE OF CHRONIC DISEASES WILL CONTRIBUTE TO MARKET GROWTH
・       TABLE 274....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 275....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 276 HUNGARY: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 277 HUNGARY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 278....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 279........... HUNGARY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 280.............. HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 281.............. HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 282.............. HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 283....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 284....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION). 218
・       TABLE 285....... HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.3.7            REST OF EUROPE
・       TABLE 286.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 287.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 288 ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 289 ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 290.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 291 ROE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 292... ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 293... ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 294... ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 295.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 296.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)
・       TABLE 297.. ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.4          ASIA
・       FIGURE 20.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
・       TABLE 298.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 299.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 300.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 301...... ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 302 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 303.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 304 ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 305.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 306.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 307.. ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 308.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 309.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)
・       TABLE 310.. ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.4.1            JAPAN
11.4.1.1          JAPAN DOMINATES THE ASIAN MARKET FOR APIS
・       TABLE 311 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 312 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 313.... JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 314.... JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 315 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 316................ JAPAN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 317 JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 318 JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 319 JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 320 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 321 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025(USD BILLION)
・       TABLE 322 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.4.2            CHINA
11.4.2.1          GOVERNMENT POLICIES TO INCREASE MEDICINE ACCESS AND AFFORDABILITY WILL SUPPORT MARKET GROWTH
・       TABLE 323 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 324 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 325.... CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 326.... CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 327 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 328................ CHINA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 329 CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 330 CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 331 CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 332 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 333 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 334 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.4.3            INDIA
11.4.3.1          INDIA IS A LEADING PRODUCER OF GENERICS
・       TABLE 335. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 336. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 337..... INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 338..... INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 339. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 340................. INDIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 341. INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 342. INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 343. INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 344. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 345. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 346. INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.4.4            SOUTH KOREA
11.4.4.1          RISING ANNUAL DRUG EXPORTS ARE LIKELY TO DRIVE MARKET GROWTH
・       TABLE 347.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 348.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION). 243
・       TABLE 349.......... SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 350.......... SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 351.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 352..... SOUTH KOREA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 353........ SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 354........ SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 355........ SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 356.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 357.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 358.. SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)

11.4.5            REST OF ASIA
・       TABLE 359.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 360.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 361 ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 362 ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 363.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 364 ROA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 365... ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 366... ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 367... ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 368.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 369.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY,
2018–2025 (USD BILLION)
・       TABLE 370.. ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.5          REST OF THE WORLD
・       TABLE 371.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
・       TABLE 372.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 373.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 374...... ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 375 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 376.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 377 ROW: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 378.. ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 379.. ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 380.. ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 381.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 382.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 383.. ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.5.1            ISRAEL
11.5.1.1          FINANCIAL SUPPORT BY THE GOVERNMENT WILL DRIVE MARKET GROWTH
・       TABLE 384 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 385 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 386... ISRAEL: MERCHANT API MANUFACTURERS MARKET, BY TYPE,
2018–2025 (USD BILLION)
・       TABLE 387... ISRAEL: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 388 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 389............... ISRAEL: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 390 ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 391 ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY PRODUCT, 2018–2025 (USD BILLION)
・       TABLE 392 ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 393 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 394 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 395 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
11.5.2            OTHER COUNTRIES.. 261
・       TABLE 396.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 397.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
・       TABLE 398.... OTHER COUNTRIES: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION). 262
・       TABLE 399.... OTHER COUNTRIES: MERCHANT API MANUFACTURERS MARKET,
BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 400.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
・       TABLE 401 OTHER COUNTRIES: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 402.. OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
・       TABLE 403.. OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION). 263
・       TABLE 404.. OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
・       TABLE 405.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY TYPE OF DRUG, 2018–2025 (USD BILLION)
・       TABLE 406.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY POTENCY, 2018–2025 (USD BILLION)
・       TABLE 407.............. OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)

12.. COMPETITIVE LANDSCAPE

12.1          OVERVIEW
12.2          MARKET EVALUATION FRAMEWORK
・       TABLE 408............. GROWTH STRATEGY MATRIX: EXPANSIONS AND COLLABORATIONS ARE THE WIDELY ADOPTED GROWTH STRATEGIES BY MARKET PLAYERS
12.3          COMPETITIVE SITUATION AND TRENDS
・       TABLE 409..... PRODUCT LAUNCHES, JANUARY 2017−AUGUST 2020
・       TABLE 410................ EXPANSIONS, JANUARY 2017−AUGUST 2020
・       TABLE 411.............. ACQUISITIONS, JANUARY 2017−AUGUST 2020
・       TABLE 412...... AGREEMENTS, COLLABORATIONS, ALLIANCES, JOINT VENTURES, AND PARTNERSHIPS, JANUARY 2017−AUGUST 2020

13.. COMPANY EVALUATION MATRIX AND COMPANY PROFILES

13.1          COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
13.2          COMPANY EVALUATION MATRIX
13.2.1            STARS
13.2.2            EMERGING LEADERS.. 270
13.2.3            PERVASIVE PLAYERS.. 271
13.2.4            EMERGING COMPANIES
・       FIGURE 21....... COMPETITIVE LEADERSHIP MAPPING OF THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET – OVERALL MARKET
13.3          COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
13.3.1            PROGRESSIVE COMPANIES
13.3.2            STARTING BLOCKS.. 272
13.3.3            RESPONSIVE COMPANIES
13.3.4            DYNAMIC COMPANIES.. 272
・       FIGURE 22....... COMPETITIVE LEADERSHIP MAPPING OF THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET - START-UPS/SMES
13.4          MARKET PLAYER RANKING
・       FIGURE 23 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PLAYER RANKING, 2019
13.5          COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
13.5.1            PFIZER, INC.
・       FIGURE 24.................. PFIZER, INC.: COMPANY SNAPSHOT (2019)
13.5.2            NOVARTIS AG
・       FIGURE 25................. NOVARTIS AG: COMPANY SNAPSHOT (2019)
13.5.3            SANOFI
・       FIGURE 26......................... SANOFI: COMPANY SNAPSHOT (2019)
13.5.4            BOEHRINGER INGELHEIM
・       FIGURE 27.. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
13.5.5            BRISTOL-MYERS SQUIBB
・       FIGURE 28.. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT (2019)
13.5.6            TEVA PHARMACEUTICAL INDUSTRIES LTD.
・       FIGURE 29..... TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2019)
13.5.7            ELI LILLY AND COMPANY
・       FIGURE 30... ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2019)
13.5.8            GLAXOSMITHKLINE PLC
・       FIGURE 31.... GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2019)
13.5.9            MERCK & CO., INC.
・       FIGURE 32.......... MERCK & CO., INC.: COMPANY SNAPSHOT (2019)
13.5.10         MYLAN N.V.
・       FIGURE 33................... MYLAN N.V.: COMPANY SNAPSHOT (2019)
13.5.11         ABBVIE INC.
・       FIGURE 34................... ABBVIE INC.: COMPANY SNAPSHOT (2019)
13.5.12         F. HOFFMANN-LA ROCHE LTD.
・       FIGURE 35...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
13.5.13         ASTRAZENECA
・       FIGURE 36................ ASTRAZENECA: COMPANY SNAPSHOT (2019)
13.5.14         DR. REDDY’S LABORATORIES LTD.
・       FIGURE 37 DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT (2019)
13.5.15         SUN PHARMACEUTICAL INDUSTRIES LTD.
・       FIGURE 38...... SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2019)
13.5.16         CIPLA, INC.
・       FIGURE 39.................... CIPLA, INC.: COMPANY SNAPSHOT (2019)
13.5.17         API PHARMA TECH
13.5.18         BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
13.5.19         SREEPATHI PHARMACEUTICALS LIMITED
13.5.20         SHILPA MEDICARE LIMITED
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.. APPENDIX



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。